Autologous Stem Cell Therapy in Stroke

Neurogen Brain and Spine Institute

Status and phase: Withdrawn; Phase 1

Conditions: Stroke

Treatments: Biological: Stem cell

Study type: Interventional

Funder types: Other

Identifiers

NCT02245698

NGBSI-11

Details and patient eligibility

About

The purpose of this study was to study the safety and effect of stem cell therapy on the functional recovery in patients with sub acute/chronic stroke.

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age18 years-80 years
• diagnosed as stroke by clinical and MRI findings

Exclusion criteria

• presence of respiratory distress
• presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/ Hepatitis C Virus
• malignancies
• acute medical conditions such as respiratory infection, fever
• hemoglobin less than 8
• bleeding tendency
• bone marrow disorder
• left ventricular ejection fraction < 30%
• pregnancy or breastfeeding

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

Stem Cell

Experimental group

Description:

Bone marrow mononuclear cells

Treatment:

Biological: Stem cell